Your browser doesn't support javascript.
loading
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.
Rubatto, Marco; Fava, Paolo; Stanganelli, Ignazio; Ribero, Simone; Pigozzo, Jacopo; Di Giacomo, Anna Maria; Ridolfi, Laura; Tronconi, Maria Chiara; Trojaniello, Claudia; Bersanelli, Melissa; Garutti, Mattia; Indini, Alice; De Risi, Ivana; De Tursi, Michele; Merelli, Barbara; Morgese, Francesca; Occelli, Marcella; Cappellini, Gian Carlo Antonini; Poletto, Stefano; Fedele, Dahlia; Brugnara, Sonia; Frisinghelli, Michela; Formisano, Luigi; Conca, Raffaele; Tucci, Marco; Russillo, Michelangelo; Ceroni, Luca; Queirolo, Paola; Targato, Giada; Strippoli, Sabino; Mandalà, Mario; Guida, Michele; Quaglino, Pietro.
Afiliação
  • Rubatto M; Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy. Electronic address: rubattomarco@gmail.it.
  • Fava P; Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy.
  • Stanganelli I; Skin Cancer Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Meldola, Italy.
  • Ribero S; Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy.
  • Pigozzo J; Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.
  • Ridolfi L; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Tronconi MC; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center - IRCCS, Milan, Italy.
  • Trojaniello C; Department of Melanoma and Cancer Immunotherapy, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
  • Bersanelli M; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy.
  • Garutti M; CRO Aviano National Cancer Institute IRCCS, 33081 Aviano, Italy.
  • Indini A; Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • De Risi I; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy.
  • De Tursi M; Department of Medical, Oral and Biotechnological Sciences, Gabriele d'Annunzio University of Chieti and Pescara, Chieti, Italy.
  • Merelli B; Unit of Medical Oncology, Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Piazza OMS 1, 24100 Bergamo, Italy.
  • Morgese F; Clinica Oncologica, Università Politecnica delle Marche, AOU Ospedali Riuniti Di Ancona, Ancona, Italy.
  • Occelli M; Department of Medicine, Clinical Oncology and Translational Research, Azienda Ospedaliera Santa Croce and Carle University Teaching Hospital, Cuneo, Italy.
  • Cappellini GCA; UOC Oncologia Interpresidio, Ospedale Sandro Pertini, ASL Roma 2, Roma, Italy.
  • Poletto S; Istituto di Candiolo, FPO - IRCCS, Candiolo, Italy; Department of Oncology, University of Turin, Torino, Italy.
  • Fedele D; Skin Cancer Unit, Department of Medical Oncology, Maggiore Hospital of Trieste, Trieste, Italy.
  • Brugnara S; Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy.
  • Frisinghelli M; Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy.
  • Formisano L; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
  • Conca R; Division of Medical Oncology, Department of Onco-Hematology, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero, Vulture, Italy.
  • Tucci M; Department of Biomedical Sciences and Clinical Oncology, University of Bari 'Aldo Moro', Section of Internal Medicine and Oncology, P.za Giulio Cesare, 11, 70124 Bari, Italy.
  • Russillo M; Department of Cancer Medicine, Istituto Regina Elena, Rome, Italy.
  • Ceroni L; University of Turin, Turin, Italy.
  • Queirolo P; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Targato G; Department of Medical Oncology, Academic Hospital of Udine, Italy.
  • Strippoli S; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy.
  • Mandalà M; Unit of Medical Oncology, University of Perugia, Perugia, Italy.
  • Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy.
  • Quaglino P; Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy.
Eur J Cancer ; 187: 25-35, 2023 07.
Article em En | MEDLINE | ID: mdl-37099946
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Melanoma / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Melanoma / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article